News

EPFL scientists have developed an animal model for breast cancer that faithfully captures the disease. Tested on human breast tissue, this the most clinically realistic model for breast cancer to date.

The genomic sequencing of hundreds of patients with diverse types of ciliopathies has revealed that "in many cases the gene responsible is not known", says Travis Stracker, head of the Genomic Instability and Cancer Lab at the IRB Barcelona.

Company has announced collaboration to develop and commercialize novel diagnostic test to predict response to keytruda® (pembrolizumab) Merck's anti-PD-1 therapy.

Company has announced conditional approval status for RosettaGX Reveal™, its novel microRNA classifier for the diagnosis of indeterminate thyroid fine needle aspirate.

Scientists from Colorado State University have explored the use of small molecules in patient serum for diagnosis of dengue fever and potentially predicting progression to the severe disease.

A new study that assesses the accuracy of modern human-genome-sequencing technologies found that some medically significant portions of an individual’s DNA blueprint are situated in complex, hard-to-analyze regions that are currently prone to systematic errors.

Company has announced the guidelines provide recommendations to ensure that patients receive diagnostic testing services and treatment that have been shown to improve clinical outcomes.

SomaLogic, Inc., and Visium Healthcare Partners, LP has announced that SomaLogic will receive up to $60.5 million through a combination of debt and equity financing from Visium.

A study by J. William Harbour, M.D., Associate Director for Basic Research and leader of the Eye Cancer Site Disease Group at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, and colleagues details the discovery of a biomarker that puts patients at a higher risk for metastasis of uveal melanoma.

Researchers at Neuro-Bio have now validated a novel theory for the continuing cycle of neuronal death that typifies Alzheimer’s and other neurodegenerative disorders.